Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Australia to extend and fund Hep B screening

This article was originally published in Clinica

Executive Summary

Demand for the hepatitis B virus DNA screening test (HBV DNA) is set to increase in Australia, following a decision to make screening for migrants from Hep B "hotspots", such as South-East Asia, mandatory. Annual testing for Hep B carriers is also on the cards - recent advice to doctors states that carriers of the virus should be monitored on a yearly basis.

Advertisement
Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT050094

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel